Biotechnology

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

SHANGHAI, July 23, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) inShanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have successfully passed two...

2019-07-23 12:48 3461

Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center

SYDNEY, July 22, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that Memorial Sloan Kettering Cancer Center (MSK) inNew York, NY will investigate the potential use of Kazia's investigational ne...

2019-07-22 09:08 3832

Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US

SUZHOU, China and ROCKVILLE, Md., July 22, 2019 /PRNewswire/ -- Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced that the company was notified by the U.S. Food ...

2019-07-22 07:00 3071

Kazia calls for greater awareness of the deadliest brain cancer in the US

SYDNEY, July 17, 2019 /PRNewswire/ -- This Glioblastoma Awareness Day, Australian oncology-focused biotech company, Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA), calls for greater awareness of the most lethal brain cancer in the US. Glioblastoma (GBM) is the most common, complex, treatment ...

2019-07-17 20:00 7803

Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., July 17, 2019 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced that it will launch the new VRNxT(TM), a volume reduction instrument optimized to remove manual sample volume reduction steps i...

2019-07-17 08:15 3544

Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline

SINGAPORE, July 10, 2019 /PRNewswire/ -- Hummingbird Bioscience, a Singapore founded biotech company focused on the discovery and development of novel antibody-based therapeutics, today announced the successful completion of an extended Series A financing round. The round was led by Heritas Capit...

2019-07-10 15:09 2900

Accutest Biologics Private Limited (ABPL) Receives the Prestigious OECD-Good Laboratory Practice (GLP) Certification, a First-of-its-kind in India

MUMBAI, India, July 9, 2019 /PRNewswire/ -- India-based Accutest Biologics Private Limited (ABPL), a leading CRO for high-quality Biochemical characterization and Bioanalytical services supporting preclinical and clinical development of Biologics and Biosimilars, has received the prestigious OEC...

2019-07-09 14:30 2715

ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia

MELBOURNE, Australia, July 6, 2019 /PRNewswire/ --  The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch ofGene Therapy in Hemophilia: An ISTH Education Initiative. This landmark launch, the first of its kind in hemophilia, will take place duri...

2019-07-06 06:00 3422
1 ... 285286287288289